Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 607137, 9 pages
http://dx.doi.org/10.1155/2013/607137
Clinical Study

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody

1Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Tomioka, Urayasu-shi, Chiba 279-0021, Japan
2Department of Internal Medicine, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba 279-0021, Japan
3Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
4Department of Rheumatology, Kohnodai Hospital, National Center for Global Health and Medicine, 1-7-1 Kohnodai, Ichikawa-shi, Chiba 272-8516, Japan

Received 26 April 2013; Accepted 17 July 2013

Academic Editor: Vinod Chandran

Copyright © 2013 Mitsuaki Yanagida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mitsuaki Yanagida, Mikiko Kawasaki, Maki Fujishiro, et al., “Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody,” BioMed Research International, vol. 2013, Article ID 607137, 9 pages, 2013. https://doi.org/10.1155/2013/607137.